Casebook consults: improving outcomes in gout (multimedia activity)

Area of Science:

• Rheumatology
• Internal Medicine
• Clinical Immunology

Background:

• Gout is a chronic inflammatory joint disease caused by monosodium urate crystal deposition.
• Underdiagnosis and undertreatment can lead to severe complications like tophi and chronic arthropathy.
• Accurate diagnosis requires differentiating gout from conditions such as septic arthritis, pseudogout, and rheumatoid arthritis.

Purpose of the Study:

• To provide a comprehensive overview of gout diagnosis and management.
• To emphasize the importance of achieving target serum uric acid levels with urate-lowering therapy (ULT).
• To highlight the role of patient education in long-term disease control.

Main Methods:

• Clinical presentation and risk factors (e.g., metabolic syndrome) aid presumptive diagnosis.
• Acute gout flares are managed with NSAIDs, colchicine, or corticosteroids.
• Urate-lowering therapy (ULT) initiated after acute flares, with prophylaxis and dose titration to target serum uric acid (SUA) levels.

Main Results:

• Achieving SUA levels ≤6.0 mg/dL with ULT significantly reduces gout attacks.
• ULT is effective in preventing recurrent flares and managing chronic gout.
• Patient adherence to long-term ULT is essential for sustained disease control.

Conclusions:

• Clinicians should confidently diagnose and manage gout, including initiating ULT.
• Targeting SUA levels ≤6.0 mg/dL is the primary goal of gout treatment.
• Effective patient education is vital for adherence to lifelong ULT and optimal disease management.